Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression

Table 2 Values of heterogeneity and Beta on log HR in the meta-regression

	I²	P-value of heterogeneity	Beta on log (HR)	P-value	R²
MACE	40%	0.040	− 0.298	0.007	97%
CV death	39%	0.047	− 0.176	0.311	4%
Non-fatal MI	30%	0.108	− 0.181	0.256	3%
Non-fatal stroke	21%	0.206	− 0.531	0.008	100%
Heart failure	70%	< 0.001	− 0.186	0.474	0%
All-cause death	48%	0.012	− 0.196	0.192	24%

ISSN: 1475-2840